Genomic Medicine

The Sorcerer's New Broom? the Limitations of the Human Genome Project

Published in: Western Journal of Medicine, v. 175, Dec. 2001, p. 424-426

Posted on RAND.org on December 31, 2000

by Ian D. Coulter

Read More

Access further information on this document at www.ewjm.com

This article was published outside of RAND. The full text of the article can be found at the link above.

Many believe that the human genome project will transform the way contemporary medicine is practiced, leading to disease being redefined in terms of biological or biochemical events. This paradigm shift, in turn, may help physicians diagnose and ultimately treat patients using gene therapy, aided by new drugs that target a patient's specific genetic profile. Despite the achievements of genomic medicine, evidence of its limitations is accumulating. Perhaps the most negative effect of the human genome project might come in its diversion of resources, scientists, and physicians from other promising medical paradigms. In his commentary, the author reviews the crisis in biomedicine, the dominant paradigm in the twentieth century, out of which have emerged four trends in medicine: the re-emergence of a holistic paradigm, Engel's biopsychosocial paradigm, phenomenology, and humanistic medicine. These movements share a dissatisfaction with biomedicine and a feeling that its reductionism and emphasis on technology have diminished both medicine and the patient and resulted in uncontrollable costs. The author warns that genomic medicine runs the risk of diverting the attention of medicine away from what the public and its critics have been saying, at a time when it seems as if medicine was adopting a more holistic paradigm. He cautions that the seduction of genomic medicine might blind the medical profession to the message that medicine is about people, not genes.

This report is part of the RAND Corporation External publication series. Many RAND studies are published in peer-reviewed scholarly journals, as chapters in commercial books, or as documents published by other organizations.

Our mission to help improve policy and decisionmaking through research and analysis is enabled through our core values of quality and objectivity and our unwavering commitment to the highest level of integrity and ethical behavior. To help ensure our research and analysis are rigorous, objective, and nonpartisan, we subject our research publications to a robust and exacting quality-assurance process; avoid both the appearance and reality of financial and other conflicts of interest through staff training, project screening, and a policy of mandatory disclosure; and pursue transparency in our research engagements through our commitment to the open publication of our research findings and recommendations, disclosure of the source of funding of published research, and policies to ensure intellectual independence. For more information, visit www.rand.org/about/principles.

The RAND Corporation is a nonprofit institution that helps improve policy and decisionmaking through research and analysis. RAND's publications do not necessarily reflect the opinions of its research clients and sponsors.